Dr. Reddy's Laboratories Ltd. - Research Center
500124 DRREDDY Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
| Operating profit | 5,926.40 | 4,214.80 | 2,594.10 | 3,136.80 | 2,869.60 |
| Interest | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 |
| Gross profit | 6,766.90 | 4,789.20 | 3,038.10 | 3,891.20 | 3,565.00 |
| EPS (Rs) | 260.31 | 156.83 | 97.55 | 131.39 | 176.76 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
| Stock adjustment | -238.80 | 129.50 | -389.60 | -395.60 | -99.90 |
| Raw material | 3,291.50 | 3,161.40 | 3,378.40 | 3,266.30 | 2,556.50 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | 4,839.80 | 4,320.80 | 3,804.20 | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 7,393.00 | 1,779.30 | 2,057.10 | 1,252.30 | 4,494.00 |
| Provisions made | 26.00 | 5.10 | 9.80 | 15.00 | - |
| Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 |
| Taxation | 1,449.30 | 1,253.20 | 600.60 | 869.80 | -161.90 |
| Net profit / loss | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 83.40 | 83.30 | 83.20 | 83.20 | 83.10 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 30.42 | 24.85 | 18.01 | 23.50 | 24.22 |
| GPM (%) | 33.26 | 27.28 | 20.41 | 27.50 | 28.31 |
| NPM (%) | 21.34 | 14.88 | 10.90 | 15.45 | 23.33 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis